Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
2.460
+0.135 (5.81%)
At close: May 12, 2025, 4:00 PM
2.560
+0.100 (4.07%)
After-hours: May 12, 2025, 5:20 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $26.49 million as of May 12, 2025. Its market cap has decreased by -64.84% in one year.
Market Cap
26.49M
Enterprise Value
-39.70M
1-Year Change
-64.84%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $26.49M, a decrease of -98.94%. That is a compound annual growth rate of -60.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 25.03M | -63.85% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |